81 related articles for article (PubMed ID: 23060593)
1. Plasma TIMP1 level is a prognostic factor in patients with liver metastases.
Bunatova K; Pesta M; Kulda V; Topolcan O; Vrzalova J; Sutnar A; Treska V; Pecen L; Liska V
Anticancer Res; 2012 Oct; 32(10):4601-6. PubMed ID: 23060593
[TBL] [Abstract][Full Text] [Related]
2. Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease.
Waas ET; Wobbes T; Ruers T; Lomme RM; Hendriks T
Eur J Surg Oncol; 2006 Sep; 32(7):756-63. PubMed ID: 16650961
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of TIMP-1 in non-small cell lung cancer.
Pesta M; Kulda V; Kucera R; Pesek M; Vrzalova J; Liska V; Pecen L; Treska V; Safranek J; Prazakova M; Vycital O; Bruha J; Holubec L; Topolcan O
Anticancer Res; 2011 Nov; 31(11):4031-8. PubMed ID: 22110238
[TBL] [Abstract][Full Text] [Related]
4. Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.
Matsushita K; Toiyama Y; Tanaka K; Saigusa S; Hiro J; Uchida K; Inoue Y; Kusunoki M
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S518-27. PubMed ID: 21845497
[TBL] [Abstract][Full Text] [Related]
5. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of serum levels of tumour markers and prognosis of recurrence and survival after liver surgery for colorectal liver metastases.
Liska V; Holubec L; Treska V; Skalicky T; Sutnar A; Kormunda S; Pesta M; Finek J; Rousarova M; Topolcan O
Anticancer Res; 2007; 27(4C):2861-4. PubMed ID: 17695461
[TBL] [Abstract][Full Text] [Related]
7. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
[TBL] [Abstract][Full Text] [Related]
8. Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer.
Tsushima H; Ito N; Tamura S; Matsuda Y; Inada M; Yabuuchi I; Imai Y; Nagashima R; Misawa H; Takeda H; Matsuzawa Y; Kawata S
Clin Cancer Res; 2001 May; 7(5):1258-62. PubMed ID: 11350892
[TBL] [Abstract][Full Text] [Related]
9. Preoperative tumor markers as prognostic factors of colorectal liver metastases.
Treska V; Topolcan O; Stanislav K; Liska V; Holubec L
Hepatogastroenterology; 2009; 56(90):317-20. PubMed ID: 19579590
[TBL] [Abstract][Full Text] [Related]
10. Impact of plasma tissue inhibitor of matrix metalloproteinase-1 on long-term survival in patients with colorectal cancer.
Yukawa N; Yoshikawa T; Akaike M; Sugimasa Y; Rino Y; Masuda M; Imada T
Oncology; 2007; 72(3-4):205-8. PubMed ID: 18160809
[TBL] [Abstract][Full Text] [Related]
11. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
Wang CS; Wu TL; Tsao KC; Sun CF
Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233
[TBL] [Abstract][Full Text] [Related]
12. Recurrence after complete cryoablation of colorectal liver metastases: analysis of prognostic features.
Yan TD; Nunn DR; Morris DL
Am Surg; 2006 May; 72(5):382-90. PubMed ID: 16719189
[TBL] [Abstract][Full Text] [Related]
13. Combined determination of plasma MMP2, MMP9, and TIMP1 improves the non-invasive detection of transitional cell carcinoma of the bladder.
Staack A; Badendieck S; Schnorr D; Loening SA; Jung K
BMC Urol; 2006 Aug; 6():19. PubMed ID: 16901349
[TBL] [Abstract][Full Text] [Related]
14. Circulating CD95-ligand as a potential prognostic marker for recurrence in patients with synchronous colorectal liver metastases.
Hoogwater FJ; Snoeren N; Nijkamp MW; Gunning AC; VAN Houdt WJ; DE Bruijn MT; Voest EE; VAN Hillegersberg R; Kranenburg O; Rinkes IH
Anticancer Res; 2011 Dec; 31(12):4507-12. PubMed ID: 22199323
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in plasma of patients with colorectal cancer.
Yukawa N; Yoshikawa T; Akaike M; Sugimasa Y; Takemiya S; Yanoma S; Imada T; Noguchi Y
Anticancer Res; 2004; 24(3b):2101-5. PubMed ID: 15274408
[TBL] [Abstract][Full Text] [Related]
16. Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases.
Yoon SS; Kim SH; Gonen M; Heffernan NM; Detwiller KY; Jarnagin WR; D'Angelica M; Blumgart LH; Tanabe KK; Dematteo RP
Ann Surg Oncol; 2006 Mar; 13(3):353-62. PubMed ID: 16474912
[TBL] [Abstract][Full Text] [Related]
17. Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience.
Nuzzo G; Giuliante F; Ardito F; Vellone M; Giovannini I; Federico B; Vecchio FM
Surgery; 2008 Mar; 143(3):384-93. PubMed ID: 18291260
[TBL] [Abstract][Full Text] [Related]
18. Difference between free circulating plasma and serum DNA in patients with colorectal liver metastases.
Thijssen MA; Swinkels DW; Ruers TJ; de Kok JB
Anticancer Res; 2002; 22(1A):421-5. PubMed ID: 12017326
[TBL] [Abstract][Full Text] [Related]
19. Plasma concentration of tissue inhibitor of matrix metalloproteinase 1 in patients with colorectal carcinoma.
Yukawa N; Yoshikawa T; Akaike M; Sugimasa Y; Takemiya S; Yanoma S; Noguchi Y; Takanashi Y
Br J Surg; 2001 Dec; 88(12):1596-601. PubMed ID: 11736971
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H
Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
